Elisabeth Quoix, et al.
16th World Conference on Lung Cancer. September 2015, Denver, Colorado
Download the poster here
Poster Presentation
TG4010 Immunotherapy plus Chemotherapy as First Line Treatment of Advanced NSCLC: Phase 2b Results.
Par alcyon|2019-07-02T17:02:34+02:00septembre 10th, 2015|Publication, TG4010|Commentaires fermés sur TG4010 Immunotherapy plus Chemotherapy as First Line Treatment of Advanced NSCLC: Phase 2b Results.
À propos de l'auteur : alcyon
Articles similaires
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity